Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "triptan" receptors: implications in migraine.

Akerman S, Holland PR, Lasalandra MP, Goadsby PJ.

J Neurosci. 2013 Sep 11;33(37):14869-77. doi: 10.1523/JNEUROSCI.0943-13.2013.

2.

Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception.

Bartsch T, Knight YE, Goadsby PJ.

Ann Neurol. 2004 Sep;56(3):371-81.

PMID:
15349864
3.

Capsaicin in the periaqueductal gray induces analgesia via metabotropic glutamate receptor-mediated endocannabinoid retrograde disinhibition.

Liao HT, Lee HJ, Ho YC, Chiou LC.

Br J Pharmacol. 2011 May;163(2):330-45. doi: 10.1111/j.1476-5381.2011.01214.x.

4.

Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons.

Akerman S, Holland PR, Goadsby PJ.

J Pharmacol Exp Ther. 2007 Jan;320(1):64-71. Epub 2006 Oct 3.

5.

Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition.

Ho YC, Lee HJ, Tung LW, Liao YY, Fu SY, Teng SF, Liao HT, Mackie K, Chiou LC.

J Neurosci. 2011 Oct 12;31(41):14600-10. doi: 10.1523/JNEUROSCI.2671-11.2011.

6.

Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state.

Rea K, Ford GK, Olango WM, Harhen B, Roche M, Finn DP.

Eur J Neurosci. 2014 Feb;39(3):435-43. doi: 10.1111/ejn.12452.

PMID:
24494683
7.

Processing cardiovascular information in the vlPAG during electroacupuncture in rats: roles of endocannabinoids and GABA.

Tjen-A-Looi SC, Li P, Longhurst JC.

J Appl Physiol (1985). 2009 Jun;106(6):1793-9. doi: 10.1152/japplphysiol.00142.2009. Epub 2009 Mar 26.

8.

Endocannabinoid regulation of spinal nociceptive processing in a model of neuropathic pain.

Sagar DR, Jhaveri MD, Richardson D, Gray RA, de Lago E, Fernández-Ruiz J, Barrett DA, Kendall DA, Chapman V.

Eur J Neurosci. 2010 Apr;31(8):1414-22. doi: 10.1111/j.1460-9568.2010.07162.x. Epub 2010 Apr 9.

PMID:
20384778
9.

Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats.

Lisboa SF, Magesto AC, Aguiar JC, Resstel LB, Guimarães FS.

Neuropharmacology. 2013 Dec;75:86-94. doi: 10.1016/j.neuropharm.2013.07.008. Epub 2013 Jul 27.

PMID:
23899460
10.

Endocannabinoid modulation of sympathetic and cardiovascular responses to acute stress in the periaqueductal gray of the rat.

Dean C.

Am J Physiol Regul Integr Comp Physiol. 2011 Mar;300(3):R771-9. doi: 10.1152/ajpregu.00391.2010. Epub 2011 Jan 12.

11.
12.

Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats.

Escobar W, Ramirez K, Avila C, Limongi R, Vanegas H, Vazquez E.

Eur J Pain. 2012 May;16(5):676-89. doi: 10.1002/j.1532-2149.2011.00057.x. Epub 2011 Dec 19.

PMID:
22337336
13.

The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors.

Batista PA, Fogaça MV, Guimarães FS.

Behav Brain Res. 2015 Oct 15;293:182-8. doi: 10.1016/j.bbr.2015.07.019. Epub 2015 Jul 14.

PMID:
26187694
14.

Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray.

Lisboa SF, Guimarães FS.

Neuropharmacology. 2012 Jun;62(8):2455-62. doi: 10.1016/j.neuropharm.2012.02.008. Epub 2012 Feb 27.

PMID:
22394688
15.

Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.

Maione S, Bisogno T, de Novellis V, Palazzo E, Cristino L, Valenti M, Petrosino S, Guglielmotti V, Rossi F, Di Marzo V.

J Pharmacol Exp Ther. 2006 Mar;316(3):969-82. Epub 2005 Nov 11.

16.

Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey.

Mitchell VA, Kawahara H, Vaughan CW.

J Physiol. 2009 Jun 1;587(Pt 11):2511-20. doi: 10.1113/jphysiol.2008.167429. Epub 2009 Apr 9.

17.

Periaqueductal gray calcitonin gene-related peptide modulates trigeminovascular neurons.

Pozo-Rosich P, Storer RJ, Charbit AR, Goadsby PJ.

Cephalalgia. 2015 Dec;35(14):1298-307. doi: 10.1177/0333102415576723. Epub 2015 Mar 19.

PMID:
25792688
18.

Electroacupuncture modulates vlPAG release of GABA through presynaptic cannabinoid CB1 receptors.

Fu LW, Longhurst JC.

J Appl Physiol (1985). 2009 Jun;106(6):1800-9. doi: 10.1152/japplphysiol.91648.2008. Epub 2009 Apr 9.

19.

Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain.

Sagar DR, Staniaszek LE, Okine BN, Woodhams S, Norris LM, Pearson RG, Garle MJ, Alexander SP, Bennett AJ, Barrett DA, Kendall DA, Scammell BE, Chapman V.

Arthritis Rheum. 2010 Dec;62(12):3666-76. doi: 10.1002/art.27698.

20.

Cannabinoid modulation of predator fear: involvement of the dorsolateral periaqueductal gray.

Lisboa SF, Camargo LH, Magesto AC, Resstel LB, Guimarães FS.

Int J Neuropsychopharmacol. 2014 Aug;17(8):1193-206. doi: 10.1017/S1461145713001788. Epub 2014 Jan 17.

PMID:
24438603
Items per page

Supplemental Content

Write to the Help Desk